Payment overview · 2025
General Payments
4 reported records · 2 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|General Practice · FARMINGTON HILLS, MI · NPI 1417935032
Verified facts
CMS Open Payments records show Jeffrey D Haller, MD received $122.47 in general payments during 2025 across 4 reported records.
Gilead Sciences, Inc. accounted for 76.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
4 reported records · 2 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | Unresolved — no canonical attribution shown | $93.96 | 76.7% | 3 | 2025 |
| ViiV Healthcare Company | Unresolved — no canonical attribution shown | $28.51 | 23.3% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $122.47 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Biktarvy Normalized: biktarvy |
Drug | Gilead Sciences, Inc. | $31.22 | 1 | 2025 |
Source payment records
|
|||||
| CABENUVA Normalized: cabenuva |
Drug | ViiV Healthcare Company | $28.51 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 834 | 215 |
| Levothyroxine Sodium | Levothyroxine Sodium | 618 | 152 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 583 | 150 |
| Amlodipine Besylate | Amlodipine Besylate | 530 | 125 |
| Lisinopril | Lisinopril | 479 | 122 |
| Losartan Potassium | Losartan Potassium | 450 | 118 |
| Omeprazole | Omeprazole | 446 | 114 |
| Metoprolol Succinate | Metoprolol Succinate | 329 | 85 |
| Escitalopram Oxalate | Escitalopram Oxalate | 302 | 61 |
| Simvastatin | Simvastatin | 302 | 74 |
| Meloxicam | Meloxicam | 284 | 84 |
| Eliquis | Apixaban | 262 | 45 |
| Metformin Hcl | Metformin Hcl | 246 | 62 |
| Sertraline Hcl | Sertraline Hcl | 214 | 40 |
| Pantoprazole Sodium | Pantoprazole Sodium | 205 | 55 |
| Methylprednisolone | Methylprednisolone | 192 | 151 |
| Furosemide | Furosemide | 184 | 51 |
| Allopurinol | Allopurinol | 175 | 37 |
| Alprazolam | Alprazolam | 171 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 168 | 50 |
| Gabapentin | Gabapentin | 167 | 47 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 166 | 40 |
| Fluticasone Propionate | Fluticasone Propionate | 164 | 60 |
| Metformin Hcl Er | Metformin Hcl | 158 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 158 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 156 | 50 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 149 | 36 |
| Glimepiride | Glimepiride | 148 | 30 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 130 | 34 |
| Ozempic | Semaglutide | 129 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 120 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 118 | 27 |
| Famotidine | Famotidine | 112 | 32 |
| Carvedilol | Carvedilol | 111 | 30 |
| Celecoxib | Celecoxib | 108 | 18 |
| Finasteride | Finasteride | 101 | 27 |
| Azithromycin | Azithromycin | 96 | 75 |
| Atenolol | Atenolol | 91 | 22 |
| Trazodone Hcl | Trazodone Hcl | 80 | 22 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 79 | 17 |
| Donepezil Hcl | Donepezil Hcl | 78 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 78 | 20 |
| Bupropion Xl | Bupropion Hcl | 77 | 14 |
| Tramadol Hcl | Tramadol Hcl | 73 | 31 |
| Potassium Chloride | Potassium Chloride | 72 | 23 |
| Valsartan | Valsartan | 70 | 18 |
| Synthroid | Levothyroxine Sodium | 68 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 66 | 33 |
| Prednisone | Prednisone | 66 | 39 |
| Amoxicillin | Amoxicillin | 65 | 58 |
| Hydralazine Hcl | Hydralazine Hcl | 62 | 15 |
| Jardiance | Empagliflozin | 61 | 15 |
| Montelukast Sodium | Montelukast Sodium | 57 | 18 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 53 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 52 | 14 |
| Nifedipine Er | Nifedipine | 51 | 16 |
| Warfarin Sodium | Warfarin Sodium | 51 | 11 |
| Mirtazapine | Mirtazapine | 50 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 48 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 48 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 35 |
| Cefdinir | Cefdinir | 47 | 35 |
| Zolpidem Tartrate | Zolpidem Tartrate | 45 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 44 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 41 | 13 |
| Trulicity | Dulaglutide | 40 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 39 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 37 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 37 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 37 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 37 | 18 |
| Pregabalin | Pregabalin | 37 | suppressed |
| Cephalexin | Cephalexin | 36 | 34 |
| Azelastine Hcl | Azelastine Hcl | 34 | 16 |
| Midodrine Hcl | Midodrine Hcl | 34 | suppressed |
| Xarelto | Rivaroxaban | 34 | suppressed |
| Bumetanide | Bumetanide | 32 | 11 |
| Alendronate Sodium | Alendronate Sodium | 30 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 30 | 14 |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 27 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 27 | 13 |
| Phenobarbital | Phenobarbital | 27 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 21 |
| Ezetimibe | Ezetimibe | 24 | 11 |
| Mupirocin | Mupirocin | 24 | 18 |
| Tradjenta | Linagliptin | 24 | suppressed |
| Hydrocortisone | Hydrocortisone | 23 | suppressed |
| Spironolactone | Spironolactone | 23 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 23 | suppressed |
| Acyclovir | Acyclovir | 22 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 22 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 18 |
| Clonazepam | Clonazepam | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Felodipine Er | Felodipine | 20 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 20 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 20 | 11 |
| Telmisartan | Telmisartan | 20 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 19 | suppressed |
| Calcitriol | Calcitriol | 19 | suppressed |
| Lansoprazole | Lansoprazole | 19 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Lorazepam | Lorazepam | 18 | 12 |
| Silodosin | Silodosin | 18 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 17 | suppressed |
| Eplerenone | Eplerenone | 17 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 15 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | 13 |
| Dutasteride | Dutasteride | 15 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Glyburide | Glyburide | 14 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Januvia | Sitagliptin Phosphate | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 14 |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Qvar Redihaler | Beclomethasone Dipropionate | 14 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 14 | suppressed |
| Sotalol | Sotalol Hcl | 14 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 13 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 13 | suppressed |
| Repaglinide | Repaglinide | 13 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 12 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $122.47 · 4 records | Gilead Sciences, Inc. | Biktarvy, CABENUVA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error